|
Myocardial Infarction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, the expressions of miR-590-3p and ZEB1 were identified in infarct area of MI model in pigs.
|
31675172 |
2020 |
|
Barrett Esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Dysplastic BE tissues also had significantly increased levels of ZEB1 and significantly decreased levels of CDH1 compared with nondysplastic BE tissues.
|
30268789 |
2019 |
|
Renal Cell Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
ZEB1 and JUN were both found to be involved in the role of miR-429 in RCC.
|
31550675 |
2019 |
|
Colitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
ZEB1 was induced in the colonic epithelium of UC and of mouse models of colitis.
|
31366457 |
2019 |
|
Ulcerative Colitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
ZEB1 was induced in the colonic epithelium of UC and of mouse models of colitis.
|
31366457 |
2019 |
|
Peptic Esophagitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Columnar-lined esophagus of rats with reflux esophagitis had increased expression of ZEB1/2 and decreased expression of CDH1 compared with controls.
|
30268789 |
2019 |
|
Gonorrhea
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CONCLUSIONS ZEB1 expression is increased in GC tumor tissues and is associated with pathological features.
|
30829316 |
2019 |
|
Hyperglycemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Quantitative stable isotope labeling by amino acids in cell culture (SILAC) proteomics was used to elucidate the effect of elevated ZEB1, as noted during hyperglycemia.
|
31439646 |
2019 |
|
Leukemia, Myelocytic, Acute
|
0.010 |
Biomarker
|
disease |
BEFREE |
The findings of this study suggest inclusion of SNAI1 and ZEB1 genes expression in the cluster of potential genetic biomarkers to be studied in AML cases as diagnostic and prognostic markers.
|
31055699 |
2019 |
|
Lichen Planus
|
0.010 |
Biomarker
|
disease |
BEFREE |
TWIST1 and ZEB1 stainings were negative in the epithelium in both lichen planus and controls.
|
31228209 |
2019 |
|
Liver diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Numerous studies have demonstrated that abnormal expression of ZEB1 in many types of liver disease including hepatocellular carcinoma (HCC).
|
31712061 |
2019 |
|
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of Zeb1 can attenuate Nodal-induced malignancy of NB cells.
|
30985990 |
2019 |
|
Retinoblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, these findings suggest that XIST may facilitate the progression of RB through acting as a ceRNA for miR-101 to mediate the expression of ZEB1 and ZEB2.
|
30472203 |
2019 |
|
Schizophrenia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The schizophrenia associated ZEB1 gene encodes a transcription factor susceptible to transcriptional control by a hypoxia induced factor, HIF1A, known to be implicated in blood-brain barrier dysfunction.
|
30144413 |
2019 |
|
Lichen Planus, Oral
|
0.010 |
Biomarker
|
disease |
BEFREE |
Based on the present study, the role of TWIST1 and ZEB1 in oral lichen planus remains unclear.
|
31228209 |
2019 |
|
Malignant Meningioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Bioinformatics analysis and mechanism experiments demonstrated that LINC00702 acted as the molecular sponge of miR-4652-3p to upregulate ZEB1 in malignant meningioma.
|
30849635 |
2019 |
|
Schnyder crystalline corneal dystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
The clinical findings suggested co-occurrence of PPCD3 and Schnyder corneal dystrophy in the proband.
|
30950897 |
2019 |
|
Metastatic non-small cell lung cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here we apply two independent screens, BioID and an Epigenome shRNA dropout screen, to define ZEB1 interactors that are critical to metastatic NSCLC.
|
31719531 |
2019 |
|
Solid Neoplasm
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Therefore, we performed the present meta-analysis to evaluate the prognostic value of ZEB-1 in patients with solid tumors.
|
31248382 |
2019 |
|
Laryngeal Squamous Cell Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A secondary end-point was to conduct a preliminary clinical and pathological investigation into the possible role of β-arrestin-1 in the epithelial-to-mesenchymal transition (EMT), identified by testing for E-cadherin, Zeb1, and Zeb2 expression, in the setting of LSCC.
|
30854928 |
2019 |
|
Malignant mesothelioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Since <i>SNAIL-1</i>, <i>Twist</i>, and <i>ZEB-1</i> have been shown to be overexpressed in MM, these genes could be considered possible predictive or diagnostic markers of MM development.
|
30609805 |
2019 |
|
Muscle damage
|
0.010 |
PosttranslationalModification
|
phenotype |
BEFREE |
Macrophages in Zeb1-deficient injured muscles show lower phosphorylation of p38 and its forced activation reverts the enhanced muscle damage and poorer regeneration.
|
30910999 |
2019 |
|
Peritoneal Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, we demonstrated that miR-200a inhibition of PF in vivo was associated with the suppression of ZEB1 and 2, which were proved to be the target of miR-200a in our previous study.
|
30888602 |
2019 |
|
Squamous cell carcinoma of skin
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Silencing of EPHB2 in the human cSCC cell line A431 induced epithelial-mesenchymal transition (EMT)-like morphological changes accompanied by a significant upregulation of epithelial-mesenchymal transition-associated genes such as zinc finger E-box binding homeobox 1/2.
|
30881495 |
2019 |
|
Gastro-esophageal reflux disease with esophagitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Columnar-lined esophagus of rats with reflux esophagitis had increased expression of ZEB1/2 and decreased expression of CDH1 compared with controls.
|
30268789 |
2019 |